학술논문
PRIM2: A Marker of MYC-driven Hyper-proliferation, Disease Progression, Tumor Aggressiveness and Poor Survival in Glioma Patients.
Document Type
Article
Author
Source
Cancer Genomics & Proteomics (1109-6535); Mar/Apr2024, Vol. 21 Issue 2, p186-202, 17p
Subject
Language
ISSN
11096535
Abstract
Copyright of Cancer Genomics & Proteomics (1109-6535) is the property of International Institute of Anticancer Research and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)